A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity ...

Prediabetes affects 634.8 million adults globally, i.e., approximately 12% of the adult population (IDF, 2025), with 30.4% ...

Updates to NICE type 2 diabetes treatment recommendations and how nurses in primary care can implement the changes safely and ...

Smoking among people living with type 2 diabetes (T2D) is a major driver of cardiovascular morbidity and premature mortality, ...

Chronic low-grade inflammation is recognized as a component associated with insulin resistance and the progression of type 2 diabetes (T2D). In parallel, ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...

Smoking among people living with type 2 diabetes (T2D) is a major driver of cardiovascular morbidity and premature mortality, ...

A new study examines the role of palmitic acid and oleic acid—among the main fatty acids in the diet—in the development of ...

Living with type 2 diabetes can be stressful and exhausting. There’s so much to keep up with to manage your blood sugar (glucose) and overall health. “People may feel overwhelmed by monitoring glucose ...

JAMMU, Mar 28: Department of Pharmacology, Shri Mata Vaishno Devi Institute of Medical Excellence (SMVDIME), conducted a Journal Club presentation on the topic “Recent Advances in the Pharmacological ...

March 19 (UPI) --Eli Lilly's next generation obesity drug retatrutide helped significantly reduce A1C levels for people with diabetes while helping them lose weight without a plateau, the company ...

Introduction Diabetes affects ~10% of the world’s population and is rising. Treatment costs in the UK are ~15% of the NHS budget. Diabetes-related complications can be lowered through better ...